The iron regulatory hormone hepcidin reduces ferroportin 1 contentand iron release in H9C2 cardiomyo.pdf

下载文档

2
0
约2.91万字
约 6页
2017-04-09 发布于江苏
举报
版权申诉
保障服务

The iron regulatory hormone hepcidin reduces ferroportin 1 contentand iron release in H9C2 cardiomyo.pdf

1、本文档共6页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

The iron regulatory hormone hepcidin reduces ferroportin 1 contentand iron release in H9C2 cardiomyo

Available online at istry 20 (2009) 860–865Journal of Nutritional BiochemThe iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes Xiao Hu Gea, Qin Wanga, Zhong Ming Qiana,c,?, Li Zhua,c, Fang Dub, Wing Ho Yungb, Lei Yangb, Ya Keb,? aNational Key Laboratory of Chinese Medicine and Molecular Pharmacology (Shenzhen) and Laboratory of Brain Iron Metabolism, Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong bDepartment of Physiology, The Chinese University of Hong Kong, Faculty of Medicine, NT, Shatin, Hong Kong cDepartment of Neurobiology and Neurobiochemistry and Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong 226001, Peoples Republic of China Received 19 March 2008; received in revised form 23 June 2008; accepted 31 July 2008Abstract Iron plays a key pathophysiological role in a number of cardiac diseases. Studies on the mechanisms of heart iron homeostasis are therefore crucial for understanding the causes of excessive heart iron. In addition to iron uptake, cellular iron balance in the heart also depends on iron export. We provided evidence for the existence of iron exporter ferroportin 1 (Fpn1) in the heart in a recent study. The presence of hepcidin, a recently discovered iron regulatory hormone, was also confirmed in the heart recently. Based on these findings and the inhibiting role of hepcidin on Fpn1 in other tissues, we speculated that hepcidin might be able to bind with, internalize and degrade Fpn1 and then decrease iron export in heart cells, leading to an abnormal increase in heart iron and iron mediated cell injury. We therefore investigated the effects of hepcidin on the contents of Fpn1 and iron release in H9C2 cardiomyocyte cell line. We demonstrated that hepcidin has the ability to reduce Fpn1 content as well as iron release in this cell. The similar regulation patterns of hepcidin on the Fpn1 and iron release suggested that th